Detecting Changes in Arterial Blood Volume and Cardiac Efficiency

Part of paid clinical trials in Boulder, Colorado.

Sponsor
HemoCept Inc.
Study ID
NCT07205341
Status
Recruiting
Apply to this trial

Conditions

  • Aortic Valve Stenosis

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Study Details

The objective of this Pilot Study is to demonstrate the efficacy of the Hemocept device in detecting changes in arterial blood volume and cardiac efficiency.

Key Dates

Start date
Apr 29, 2025
Status verified
Apr 2026
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
20 participants (estimated)

Primary Outcome Measure

Correlation of HemoCept device measurements with aortic valve pressure gradient changes. [ Time Frame: Perioperative; immediately before procedure, and up to 24 hours after the procedure ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Boulder HeartBoulderColorado80303
Katharine Adkins
[email protected]
303-442-2395
Jamie Doucet, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Boulder, CO

By research site
Boulder Heart· Boulder, CO

Related Studies